Position in ZTS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$1,580
-$1,020 QoQ
Shares Held
22
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,349
of 1,408 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cedar Mountain Advisors, LLC holds $100,046 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
2,954 | $46,909 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
299 | $14,133 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
22 | $11,920 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
460 | $11,320 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
183 | $8,511 | |
| 6 | PRGO |
PERRIGO Co plc
|
469 | $4,872 | |
| 7 | ZTS |
Zoetis Inc.
This page
|
22 | $1,580 | |
| 8 | ALKS |
Alkermes plc.
|
8 | $419 |
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,580 | 22 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $2,600 | 22 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,768 | 22 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,219 | 22 | Shares | Sole | 2025-10-24 | |
| 2021-06-30 | $1,490 | 8 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,259 | 8 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,324 | 8 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,322 | 8 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $1,096 | 8 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $941 | 8 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||